Equillium, Inc. (0FY.F)
| Previous Close | 1.5260 |
| Open | 1.2880 |
| Bid | 1.4140 x 0 |
| Ask | 1.4680 x 0 |
| Day's Range | 1.2880 - 1.3300 |
| 52 Week Range | 0.4035 - 2.7050 |
| Volume | |
| Avg. Volume | 512 |
| Market Cap | 46.889M |
| Beta (5Y Monthly) | 1.67 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3500 |
| Earnings Date | May 09, 2024 - May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.00 |
Simply Wall St.We're Keeping An Eye On Equillium's (NASDAQ:EQ) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. By way of example...
Business WireEquillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
LA JOLLA, Calif., April 03, 2024--Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that on April 1, 2024, the Compensation Committee of Equillium’s Board of Directors granted an inducement award consisting of a nonstatutory stock option to purchase 10,000 shares of common stock to a new employee under Equillium’s 2024 Inducement Plan. The Compensation Committee appr
Zacks5 Stocks That More Than Doubled in Q1 With More Gains Ahead
Equillium (EQ), Laird Superfood (LSF), QuantaSing (QSG), Phunware (PHUN) and Arq (ARQ) more than double in the first quarter and are expected to continue their strong performances.
